DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Settings
DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Settings
DISCOVER is a Non Interventional Study study to describe the disease management patterns and clinical evolution over three years in type 2 diabetes mellitus patients initiating a second line anti-diabetic treatment.
DISCOVER is a NIS study to describe the disease management patterns and clinical evolution over three years in type 2 diabetes mellitus patients initiating a second line anti-diabetic treatment. This study is a multi-country, multicenter, observational, prospective, longitudinal cohort study. The patients will be recruitted from countries in Latin America, Europe and Asia pac. It is estimated that approximately 13350 patients will be enrolled in total with each patient followed up for 3 years.
Inclusion Criteria:
Exclusion Criteria:
Ciudad Autonoma Buenos Aires, Argentina
Stankt Stefan Ob Stainz, Austria
Bahrain, Bahrain
Bekasi Timur, Indonesia
Az Zarqaa, Jordan
Chtoura, Lebanon
Kelantan, Malaysia
Alpen Aan Den Rijn, Netherlands
Calle, Panama
Al Jouf, Saudi Arabia
Cheonan-si, South Korea
Jeju Special Self-Governing Province, South Korea
Kairaouane, Tunisia
Tunis Belvedere, Tunisia